Trademark: 97150661
Word
(KV) KALIVIR IMMUNOTHERAPEUTICS
Status Date
Tuesday, March 12, 2024
Filing Date
Wednesday, December 1, 2021
Published for Opposition
Tuesday, January 16, 2024
1 Biological preparations for scientific research purposes
The mark consists of the letters "KV" in black between two parentheses in black with a red slash across the letters "KV," all placed next to the words "KALIVIR IMMUNOTHERAPEUTICS" in black with the second "I" in "KALIVIR" being red.
The color(s) red and black is/are claimed as a feature of the mark.
"IMMUNOTHERAPEUTICS"
Dec 4, 2021
New Application Entered
Dec 6, 2021
New Application Office Supplied Data Entered
Dec 7, 2021
Notice Of Design Search Code E-Mailed
Sep 10, 2022
Assigned To Examiner
Sep 19, 2022
Non-Final Action Written
Sep 19, 2022
Non-Final Action E-Mailed
Sep 19, 2022
Notification Of Non-Final Action E-Mailed
Mar 20, 2023
Teas Response To Office Action Received
Mar 20, 2023
Correspondence Received In Law Office
Mar 21, 2023
Teas/Email Correspondence Entered
Apr 25, 2023
Final Refusal Written
Apr 25, 2023
Final Refusal E-Mailed
Apr 25, 2023
Notification Of Final Refusal Emailed
Jul 21, 2023
Application Extension To Response Period - Received
Jul 21, 2023
Application Extension Granted/Receipt Provided
Oct 25, 2023
Teas Request For Reconsideration Received
Oct 25, 2023
Exparte Appeal Received At Ttab
Oct 25, 2023
Jurisdiction Restored To Examining Attorney
Oct 25, 2023
Ex Parte Appeal-Instituted
Dec 12, 2023
Correspondence Received In Law Office
Dec 12, 2023
Teas/Email Correspondence Entered
Dec 12, 2023
Approved For Pub - Principal Register
Dec 12, 2023
Exparte Appeal Terminated
Dec 27, 2023
Notification Of Notice Of Publication E-Mailed
Jan 16, 2024
Published For Opposition
Jan 16, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2024
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24
